Abiopharma

🔍 Moe Christopher R. (Executive)

Company: Beeline Holdings, Inc. (BLNE)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 75,000 shares of Stock Options (Right to Buy) at $2.21 per share (Derivative)
  Date: 2026-04-02 | Code: A | Expires: 2036-04-02 | equity_swap_involved: 0 | shares_owned_after: 75,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options were granted under the Issuer's Amended and Restated 2025 Equity Incentive Plan, vesting on the last day of each month in equal monthly installments over 9 months with the first vesting on April 2, 2026, subject to continued service with the Company on each applicable vesting date.